Purpose-built for physicians New data links GLP-1 agonists for weight loss with higher risk for pancreatitis, GI events Key takeaways: GLP-1 agonists were associated with a 9.09 times increased risk for pancreatitis
In one study, the phytochemical inhibited both obesity and obesity-related inflammation, evidenced by a reduction in body mass and white adipose tissue as well as the downregulation of NF-B and MAPKs
Originally isolated from gastric juice, Body Protection Compound-157 (BPC157) is a synthetic peptide known for its accelerated healing effects particularly in soft tissues, tendons, ligaments, and even the gut lining
If you already deal with panic attacks, this is a big red flag
Funding This research was funded by Conselho Nacional de Desenvolvimento Cientfico e Tecnolgico (CNPq), Coordenao de Aperfeioamento de Pessoal de Nvel Superior (CAPES), Fundao Amaznia Paraense de Amparo Pesquisa (FAPESPA), and Federal University of Par (UFPA)